Short interest in Innate Pharma SA (NASDAQ:IPHA) increased during the last reporting period, rising from 105.43K to 152.46K. This put 0.31% of the company's publicly available shares short.

Short interest for Innate Pharma gives investors a sense of the degree to which investors are betting on the decline of Innate Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 51.67K shares traded per day, it would take 2.95 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.